AC8 1.92% 13.3¢ auscann group holdings ltd

Ann: Change of Director's Interest Notice - M. Washer, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 103 Posts.
    lightbulb Created with Sketch. 18
    Whilst your ability to find articles on the internet is nothing short of astounding, you’ve wasted space regurgitating information that is already well known about cannabis oils.
    Auscann’s value lies in the fact that it has successfully developed a hard capsule that stabilizes these oils - specifically for the purpose of simple long term storage and predicable dose.
    Unless the company is defrauding the market, it is the only company to have achieved this capacity - so yes, it has no competition from universities or otherwise.
    Furthermore the process they have developed is repeatable on a larger scale, as evidenced by the recent announcement regarding a manufacturing partnership.
    The next few months will see sufficient quantities of the capsule produced by a third party so that broader clinical trials can begin.
    Unless you have inside information regarding fraud (in which case you should be clear about it) ingnoring the intellectual property Auscann holds with their hard capsule is dishonest.
    Clinical trials will prove for certain one way or another, but if you are calling the company a scam then offer some evidence to support your claims. There are many articles on the internet, is there one which disproves the company’s announcements regarding the status of its hard capsule development?
 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.